$30.52
PetIQ is a drug manufacturers - specialty & generic business based in the US. PetIQ shares (PETQ) are listed on the NASDAQ and all prices are listed in US Dollars. PetIQ employs 1,121 staff and has a trailing 12-month revenue of around $1.1 billion.
Our top picks for where to buy PetIQ stock
How to buy PetIQ stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PETQ. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy PetIQ stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
PetIQ stock price (NASDAQ: PETQ)
Use our graph to track the performance of PETQ stocks over time.PetIQ shares at a glance
Latest market close | $30.53 |
---|---|
52-week range | $15.09 - $30.68 |
50-day moving average | $24.96 |
200-day moving average | $20.01 |
Wall St. target price | $29.67 |
PE ratio | 82.5676 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.37 |
Is it a good time to buy PetIQ stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PetIQ price performance over time
Historical closes compared with the close of $30.53 from 2024-09-03
1 week (2024-08-29) | 0.03% |
---|---|
1 month (2024-08-05) | 47.49% |
3 months (2024-06-05) | 43.00% |
6 months (2024-03-05) | 84.25% |
1 year (2023-09-05) | 67.84% |
---|---|
2 years (2022-09-02) | 251.73% |
3 years (2021-09-03) | 13.37% |
5 years (2019-09-05) | 3.91% |
Is PetIQ stock undervalued or overvalued?
Valuing PetIQ stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetIQ's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PetIQ's P/E ratio
PetIQ's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 83x. In other words, PetIQ shares trade at around 83x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PetIQ's PEG ratio
PetIQ's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5616. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetIQ's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PetIQ's EBITDA
PetIQ's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $101.7 million.
The EBITDA is a measure of a PetIQ's overall financial performance and is widely used to measure a its profitability.
PetIQ financials
Revenue TTM | $1.1 billion |
---|---|
Operating margin TTM | 8.63% |
Gross profit TTM | $209.7 million |
Return on assets TTM | 4.86% |
Return on equity TTM | 5.52% |
Profit margin | 1.16% |
Book value | $8.71 |
Market Capitalization | $913 million |
TTM: trailing 12 months
PetIQ share dividends
We're not expecting PetIQ to pay a dividend over the next 12 months.
PetIQ share price volatility
Over the last 12 months, PetIQ's shares have ranged in value from as little as $15.09 up to $30.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetIQ's is 1.737. This would suggest that PetIQ's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PetIQ overview
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names.
Frequently asked questions
What percentage of PetIQ is owned by insiders or institutions?Currently 6.985% of PetIQ shares are held by insiders and 101.555% by institutions. How many people work for PetIQ?
Latest data suggests 1,121 work at PetIQ. When does the fiscal year end for PetIQ?
PetIQ's fiscal year ends in December. Where is PetIQ based?
PetIQ's address is: 230 East Riverside Drive, Eagle, ID, United States, 83616 What is PetIQ's ISIN number?
PetIQ's international securities identification number is: US71639T1060 What is PetIQ's CUSIP number?
PetIQ's Committee on Uniform Securities Identification Procedures number is: 71639T106
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Streitwise review
An online REIT with low fees, consistent dividends and a stable portfolio, but a brief track record.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question